Condition
Inflamatory Bowel Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Inflamatory Bowel Disease clinical trials that are recruiting, at sites in 3 countries (most in China (4), United States (2), Switzerland (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 3Countries
Newest Inflamatory Bowel Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Impact of sucralose on gut health in Crohn's disease | — | Chagrin Falls, Ohio and 2 other locations | Recruiting | Aug 18, 2026 |
| Postoperative biologic therapy in Crohn's disease: which agent works best to prevent recurrence after surgery? | — | Shanghai, Shanghai Municipality | Recruiting | Jul 10, 2026 |
| Fecal microbiome signature of multi-strain probiotic supplementation in children and adolescents with inflammatory bowel disease | — | Bern | Recruiting | Apr 16, 2026 |
| Guselkumab for adults with Crohn's disease after ustekinumab failure | — | Hangzhou, Zhejiang | Recruiting | Mar 23, 2026 |
| Guselkumab plus a JAK inhibitor for difficult-to-treat inflammatory bowel disease | — | Hangzhou, Zhejiang | Recruiting | Mar 23, 2026 |
| 68Ga-FAPI-46 PET/CT to detect small bowel fibrostenosis in Crohn's disease | Early Phase 1 | Rochester, Minnesota | Recruiting | Dec 9, 2025 |
| Model to predict which biologic works best for inflammatory bowel disease patients | — | Beijing | Recruiting | Sep 18, 2025 |
All recruiting trials (7)
-
Impact of sucralose on gut health in Crohn's disease
This study tests whether the non-nutritive sweetener sucralose changes gut bacteria in adults with Crohn's disease compared to healthy controls.
-
Postoperative biologic therapy in Crohn's disease: which agent works best to prevent recurrence after surgery?
This study looks back at adults with Crohn's disease to see if different biologic medicines given after ileocecal or other bowel surgery help prevent endoscopic recurrence within a year.
-
Fecal microbiome signature of multi-strain probiotic supplementation in children and adolescents with inflammatory bowel disease
We will test whether giving a multi-strain probiotic changes the gut microbiome in kids and teens with inflammatory bowel disease.
-
Guselkumab for adults with Crohn's disease after ustekinumab failure
This study will try guselkumab for adults with moderate to severe Crohn's disease who did not respond to or could not tolerate ustekinumab to see if they reach remission after 52 weeks.
-
Guselkumab plus a JAK inhibitor for difficult-to-treat inflammatory bowel disease
This project will try guselkumab together with a JAK inhibitor in people aged 14–80 whose moderate-to-severe inflammatory bowel disease has not responded to multiple other treatments.
-
68Ga-FAPI-46 PET/CT to detect small bowel fibrostenosis in Crohn's disease
This study will try whether a PET tracer called 68Ga‑FAPI‑46 can find early or developing fibrosis and strictures in the small bowel of adults with Crohn's disease.
-
Model to predict which biologic works best for inflammatory bowel disease patients
This project will try to build a model that predicts which IBD patients are likely to respond to different biologic medicines using their clinical and lab data.
Related topics
Quick answers
How many Inflamatory Bowel Disease clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (4 trials), United States (2 trials), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.